Advanced BioMedical Technologies, Inc.
ABMT
$0.0003
$0.000150.00%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -3.68% | -3.47% | -2.64% | -- | -- |
| Total Depreciation and Amortization | 176.67% | -38.76% | -13.08% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.04% | 173.73% | 268.14% | -- | -- |
| Change in Net Operating Assets | 93.83% | 516.01% | 696.54% | -- | -- |
| Cash from Operations | 103.05% | 136.73% | 130.91% | -- | -- |
| Capital Expenditure | -272.34% | -198.28% | -905.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -272.34% | -198.28% | -905.00% | -- | -- |
| Total Debt Issued | 44.89% | -39.43% | -38.94% | -- | -- |
| Total Debt Repaid | -1,391.08% | -2,828.57% | -11,845.24% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.15% | -20.83% | -153.85% | -- | -- |
| Cash from Financing | -93.06% | -129.29% | -125.43% | -- | -- |
| Foreign Exchange rate Adjustments | 6,850.00% | 13,400.00% | 6,400.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -308.33% | -291.67% | 104.49% | -- | -- |
